Pay-for-performance: impact on diabetes. (Q47930650)

6 February 2018

title

Pay-for-performance: impact on diabetes. (English)

1 reference

6 February 2018

author

Evangelos Kontopantelis

series ordinal

2

1 reference

6 February 2018

author name string

Tim Doran

series ordinal

1

1 reference

6 February 2018

publication date

1 April 2013

1 reference

6 February 2018

published in

Current diabetes report

1 reference

6 February 2018

volume

13

1 reference

6 February 2018

issue

2

1 reference

6 February 2018

page(s)

196-204

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.1007/s11892-012-0351-y

exact match

0 references

cites work

Impact of payment method on behaviour of primary care physicians: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Systematic review: Effects, design choices, and context of pay-for-performance in health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Design choices made by target users for a pay-for-performance program in primary care: an action research approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Performance of small general practices under the UK's Quality and Outcomes Framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Measuring quality of care with routine data: avoiding confusion between performance indicators and health outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Eulogy for a quality measure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Exclusion of patients from pay-for-performance targets by English physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Effects of paying physicians based on their relative performance for quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Putting smart money to work for quality improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Early experience with pay-for-performance: from concept to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

A longitudinal examination of a pay-for-performance program for diabetes care: evidence from a natural experiment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Effects of pay for performance on the quality of primary care in England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Ethnicity and quality of diabetes care in a health system with universal coverage: population-based cross-sectional survey in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Ethnic disparities in diabetes management and pay-for-performance in the UK: the Wandsworth Prospective Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Has pay for performance improved the management of diabetes in the United Kingdom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Impact of a pay-for-performance incentive scheme on age, sex, and socioeconomic disparities in diabetes management in UK primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Diabetes prevalence, process of care and outcomes in relation to practice size, caseload and deprivation: national cross-sectional study in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Economic incentives in general practice: the impact of pay-for-participation and pay-for-compliance programs on diabetes care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

The effect of improving processes of care on patient outcomes: evidence from the United Kingdom's quality and outcomes framework.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Does higher quality of diabetes management in family practice reduce unplanned hospital admissions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

The psychological consequences of money.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Biomedicine, holism and general medical practice: responses to the 2004 General Practitioner contract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Too Little? Too Much? Primary care physicians' views on US health care: a brief report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Impact of financial incentives on clinical autonomy and internal motivation in primary care: ethnographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Blood pressure recording bias during a period when the Quality and Outcomes Framework was introduced.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Trends and transient change in end-digit preference in blood pressure recording: studies of sequential and longitudinal collected primary care data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Pay-for-performance programs in family practices in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Deprivation and quality of primary care services: evidence for persistence of the inverse care law from the UK Quality and Outcomes Framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

The unintended consequence of diabetes mellitus pay-for-performance (P4P) program in Taiwan: are patients with more comorbidities or more severe conditions likely to be excluded from the P4P program?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Using the UK primary care Quality and Outcomes Framework to audit health care equity: preliminary data on diabetes management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

The other side of quality improvement in diabetes for seniors: a proposal for an overtreatment glycemic measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

How to identify when a performance indicator has run its course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Quality of Primary Care in England with the Introduction of Pay for Performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Pay for perfomance and the quality of diabetes management in individuals with and without co-morbid medical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Effect of financial incentives on inequalities in the delivery of primary clinical care in England: analysis of clinical activity indicators for the quality and outcomes framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Exclusion of patients from quality measurement of diabetes care in the UK pay-for-performance programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0351-Y

Incentives and health policy: primary and secondary care in the British National Health Service

21 January 2018

1 reference

12 December 2020

Differences in patient reports on the quality of care in a diabetes pay-for-performance program between 1 year enrolled and newly enrolled patients

1 reference

12 December 2020

A pay-for-performance program for diabetes care in Taiwan: a preliminary assessment.

1 reference

12 December 2020

The relationship between social deprivation and the quality of primary care: a national survey using indicators from the UK Quality and Outcomes Framework

1 reference

12 December 2020

Provider behavior under prospective reimbursement. Cost sharing and supply

1 reference

12 December 2020

Linking physicians' pay to the quality of care--a major experiment in the United kingdom

1 reference

12 December 2020

Workload and reward in the Quality and Outcomes Framework of the 2004 general practice contract

1 reference

12 December 2020

"The cawing of the crow...Cassandra-like, prognosticating woe"

1 reference

12 December 2020

The quality and outcomes framework of the GMS contract: a quiet evolution for 2006.

1 reference

12 December 2020

Quality of clinical primary care and targeted incentive payments: an observational study

1 reference

12 December 2020

Key issues in the design of pay for performance programs

1 reference

12 December 2020

10.1007/S11892-012-0351-Y

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

23266562

1 reference

6 February 2018